Typhoid: Study confirms Vi-DT conjugate vaccine is safe and immunogenic in children 6-23 months

(International Vaccine Institute) A new study conducted by IVI in collaboration with SK bioscience shows that single-dose and two-dose regimens of Vi-DT typhoid conjugate vaccine (TCV) are safe and immunogenic in children 6-23 months of age, a group with high rates of typhoid fever in resource-limited settings.